We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+1.16%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$9.68B
AUM Growth
+$282M
Cap. Flow
+$368M
Cap. Flow %
3.8%
Top 10 Hldgs %
10.65%
Holding
2,698
New
807
Increased
606
Reduced
561
Closed
588

Sector Composition

Rank Sector Weight
1 Financials 27.55%
2 Technology 14.73%
3 Healthcare 8.47%
4 Consumer Discretionary 7.67%
5 Industrials 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
551
Thermo Fisher Scientific
TMO
$214B
$3.28M 0.03%
+5,735
New +$3.15M
VRM icon
552
Vroom Inc
VRM
$49.9M
$3.26M 0.03%
+1,848
New +$4.71M
KSU
553
DELISTED
Kansas City Southern
KSU
$3.25M 0.03%
12,000
-26,445
-69% -$7.36M
DCPH
554
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$3.22M 0.03%
94,840
+56,369
+147% +$1.8M
NVST icon
555
Envista
NVST
$4.66B
$3.2M 0.03%
+76,597
New +$3.23M
WES icon
556
Western Midstream Partners
WES
$19.1B
$3.2M 0.03%
+152,510
New +$3.04M
CTLT
557
DELISTED
CATALENT, INC.
CTLT
$3.18M 0.03%
23,910
+19,213
+409% +$2.4M
AKR icon
558
Acadia Realty Trust
AKR
$2.95B
$3.17M 0.03%
155,198
+72,294
+87% +$1.52M
SOFI icon
559
SoFi Technologies
SOFI
$23.5B
$3.16M 0.03%
198,849
-743,495
-79% -$11.7M
CURO
560
DELISTED
CURO Group Holdings Corp.
CURO
$3.14M 0.03%
181,204
+73,304
+68% +$1.21M
ISEE
561
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$3.13M 0.03%
+192,800
New +$2.1M
BPOP icon
562
Popular Inc
BPOP
$11.3B
$3.13M 0.03%
40,300
-102,400
-72% -$7.62M
EWT icon
563
PUT
iShares MSCI Taiwan ETF
EWT
$10.6B
$3.1M 0.03%
+50,000
New +$3.19M
CMS icon
564
CMS Energy
CMS
$22.4B
$3.1M 0.03%
51,862
-68,440
-57% -$4.27M
ROP icon
565
Roper Technologies
ROP
$39B
$3.08M 0.03%
+6,900
New +$3.31M
AEP icon
566
American Electric Power
AEP
$68.8B
$3.08M 0.03%
37,900
-86,100
-69% -$7.52M
AMED
567
DELISTED
Amedisys
AMED
$3.08M 0.03%
+20,633
New +$4.29M
FISV
568
Fiserv Inc
FISV
$28.9B
$3.08M 0.03%
28,345
-297,207
-91% -$33.2M
CSTL icon
569
Castle Biosciences
CSTL
$929M
$3.07M 0.03%
46,136
+18,723
+68% +$1.32M
CLDX icon
570
Celldex Therapeutics
CLDX
$3.22B
$3.07M 0.03%
56,807
-20,073
-26% -$942K
ARE icon
571
Alexandria Real Estate Equities
ARE
$8.62B
$3.07M 0.03%
16,046
+7,646
+91% +$1.52M
ALK icon
572
Alaska Air
ALK
$5.81B
$3.06M 0.03%
+52,300
New +$3.01M
FERG icon
573
Ferguson
FERG
$49.5B
$3.05M 0.03%
21,834
+18,388
+534% +$2.62M
UMC icon
574
United Microelectronic
UMC
$48.4B
$3.04M 0.03%
266,100
-322,700
-55% -$3.46M
PPD
575
DELISTED
PPD, Inc. Common Stock
PPD
$3.03M 0.03%
64,800
+1,900
+3% +$87.9K

Similar funds

Schonfeld Strategic Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Schonfeld Strategic Advisors held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Schonfeld Strategic Advisors deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
  • Schonfeld Strategic Advisors added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
  • Schonfeld Strategic Advisors fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
  • Schonfeld Strategic Advisors opened 807 new positions and closed 588 in Q3 2021.
  • Schonfeld Strategic Advisors's portfolio value rose 3% quarter-over-quarter to $9.68B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.